Rise and shine. Another busy day is on the way. Indeed, the official to-do list is brimming with tasks and reminders. On the bright side, there is a shiny sun and a cool breeze wafting […]
Pfizer’s path at getting a gene therapy to market for patients with Duchenne muscular dystrophy just got a little clearer after a hazy 2021 that saw a clinical hold, an amended late-stage trial and a […]
LANGHORNE, Pa., April 28, 2022 /PRNewswire/ — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that Adam Levy, CEO […]
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 second-quarter 2022 dividend on the company’s common stock, payable June 10, 2022, to holders of the Common Stock of […]
Covid-19 vaccines for the youngest group of children (under the age of six) may soon be available — potentially in the next month — as Moderna announced on Thursday morning that it has submitted an […]
The regulator has asked Pfizer to closely monitor patients in a hospital setting for a week as part of a deal to end a study suspension that’s lasted more than four months. Click here to […]
Charlotte Allerton, Pfizer’s head of medicine design, was making dinner — omelets — with her teenage children when she got a call from the one of company’s top development officers. He was calling with interim […]
Pfizer and Biohaven clinch migraine approval in Europe, beating AbbVie to key market fkansteiner Wed, 04/27/2022 – 12:25 Click here to view original post
It took 5 years for Amgen to move its PCSK9 cholesterol drug Repatha into the blockbuster column, all while waging an unending legal war over the patents related to Sanofi and Regeneron’s rival. But the […]
It looks like the New Merck team will need to go out and recruit yet another new face to join the crew of top execs now running the multinational company after the big shakeup following […]
Copyright © 2022 Biotech Networks, LLC
